NCT06436313

Brief Summary

The success of Deep Brain Stimulation (DBS) is more correlated to fulfillment of patients' expectations, than merely improvement of motor status1. Therefore, it is of utmost importance to inform the DBS candidates as good as possible to set realistic expectations. Currently, the patient - most of the time accompanied by a family member - is informed about the surgery and its benefits and risks during the outpatient consultation of the neurologist, and later on during the consultation of the neurosurgeon. Written information is provided in the form of a booklet that the patients take home. Due to the large amount of information, not all of it can be captured by the patient. Therefore, we would like to investigate whether an additional online immersive educational session on DBS would better educate the patient. The online session is a 1-hour video call with a small group of DBS candidates and their caregivers, lead by DBS experts, where testimonials of other patients are shown, together with multiple infographics. Two weeks later their will be a second online session summarizing the information and providing the opportunity for Q\&A.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P50-P75 for not_applicable parkinson-disease

Timeline
Completed

Started Sep 2023

Typical duration for not_applicable parkinson-disease

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2023

Completed
9 months until next milestone

First Submitted

Initial submission to the registry

May 24, 2024

Completed
7 days until next milestone

First Posted

Study publicly available on registry

May 31, 2024

Completed
1.6 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 30, 2025

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2026

Completed
Last Updated

September 22, 2025

Status Verified

September 1, 2025

Enrollment Period

2.3 years

First QC Date

May 24, 2024

Last Update Submit

September 16, 2025

Conditions

Outcome Measures

Primary Outcomes (5)

  • The Parkinson's Disease Questionnaire (PDQ-39)

    This questionnaire assesses how often people with Parkinson's experience difficulties. across 8 dimensions of daily living. The total score for each dimension ranges from 0 (never have difficulty) to 100 (always have difficulty). Lower scores indicate better quality of life.

    Baseline, 3 months post op

  • MDS-UPDRS (Movement Disorders Society Unified Parkinson's Disease Rating Scale)

    Is composed of 4 parts4. Part 1 in on the non-motor aspects of experiences of daily living, with the first half begin rated by the health care professional, based on input from the patient and the caregiver; and the second half a patient questionnaire. Part 2 is on the motor aspects of experiences of daily living, which is a questionnaire filled out by the patient and the caregiver. In the 3rd part the motor condition of the patient evaluated by the physician or nurse practitioner, in meds-ON and DBS-ON condition. The fourth and final part evaluates the motor complications and is rated by the health care professional, based on input from the patient and the caregiver. The total score on the MDS-UPDRS ranges from 0 to 260. The score indicates: 0: No disability 260: Total disability.

    Baseline, 3 months post op

  • Parkinson Anxiety Scale (PAS)

    is a 12-item observer or patient-rated scale with three subscales, for persistent and episodic anxiety, and avoidance behaviour. The total score on the PAS can range from 0 to 48. Higher scores indicate greater experiences of anxiety

    Baseline, 3 months post op

  • The Beck Depression Inventory (BDI)

    Is a 21-items questionnaire that is filled out by the patient to self-rate mood-related statements. The total score can range from 0 to 63. Higher scores indicate greater severity of depressive symptoms.

    Baseline, 3 months post op

  • Structured survey

    Assesses the level of knowledge (score range: 0-110), anxiety (score range: 0-100), expectation (score range: 0-100), satisfaction (score range: 0-80).

    Baseline, one day before surgery, 3 months post op

Study Arms (2)

Educational Group

EXPERIMENTAL

Patients will receive two extra virtual educational sessions.

Other: Educational Sessions

Standard-of-Care

NO INTERVENTION

Patients will not receive any extra educational sessions. Their education will be provided as per standard-of-care by the clinical team.

Interventions

Two online educational sessions will be organized before DBS surgery. These will be scheduled between consultation with the neurologist and the consultation with the neurosurgeon. Each virtual session will last about 1 hour. Patients can login from home, together with their caregivers. The virtual sessions will be held on MS Teams virtual platform. One of the sessions will include a DBS patient where patients will have the opportunity to ask peer-to-peer questions. The session includes testimonials from patient before and after their surgery. The second session (about two weeks later) is a summary presentation, a quiz and time for Q\&A. During one of the sessions (first or second), a DBS patient (who has been implanted) can be invited to participate togive the attendees the opportunity to ask peer-to-peer questions. The quiz contains questions to assess the patients' knowledge of DBS.

Educational Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients of any age over 18 who are capable of understanding and granting informed consent.
  • Consecutive enrollment of Parkinson's disease patients, eligible for DBS surgery who will be operated in Toronto Western Hospital.
  • Targets of surgery (STN or GPi) equally in each study arm.
  • Patients must be able to follow the assessment procedure.

You may not qualify if:

  • \. people with limited digital skills (to the discretion of the PI).

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Movement Disorders Centre - Toronto Western Hospital

Toronto, Ontario, M5T 2S8, Canada

Location

MeSH Terms

Conditions

Parkinson Disease

Condition Hierarchy (Ancestors)

Parkinsonian DisordersBasal Ganglia DiseasesBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesMovement DisordersSynucleinopathiesNeurodegenerative Diseases

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor, Department of Medicine, Division of Neurology at University of Toronto, Toronto Western Hospital

Study Record Dates

First Submitted

May 24, 2024

First Posted

May 31, 2024

Study Start

September 1, 2023

Primary Completion

December 30, 2025

Study Completion

February 1, 2026

Last Updated

September 22, 2025

Record last verified: 2025-09

Locations